Five Thousand Brazilians Have Tested Oxford Vaccine with No Severe Side Effects

According to the Federal University of São Paulo the studies are progressing uneventfully. The immunizer is being developed by the pharmaceutical company AstraZeneca in partnership with Oxford University.

RIO DE JANEIRO, BRAZIL - The Oxford vaccine trials in Brazil are continuing at a speedy pace. To date, at least 5,000 volunteers have been administered the drug - or a placebo drug - and have not presented any serious adverse reactions

To read the full NEWS and much more, Subscribe to our Premium Membership Plan. Already Subscribed?